BBC icon

Virtus LifeSci Biotech Clinical Trials ETF

12 hedge funds and large institutions have $3.71M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$384K
2 +$20.4K
3 +$1.47K

Top Sellers

1 -$971K
2 -$945K
3 -$158K
4
UBS Group
UBS Group
Switzerland
-$27.6K
5
Morgan Stanley
Morgan Stanley
New York
-$7.59K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.91M
2
$940K
3
$463K
4
$213K
5
$86K
6
$37K
7
$26K
8
$16K
9
$9K
10
$7K
11
$4.72K
12
$3K
13
14
15
16